Pernilla Abrahamsson
Operationeel Directeur bij LIPUM AB
Profiel
Pernilla Abrahamsson is the founder of MD Biomedical AB.
She is currently the Chief Operating Officer at Lipum AB.
Previously, she worked as Manager-Product Development at Senzime AB from 2018 to 2019.
Dr. Abrahamsson obtained a doctorate degree from Umea Universitet.
Actieve functies van Pernilla Abrahamsson
| Bedrijven | Functie | Begin |
|---|---|---|
| LIPUM AB | Operationeel Directeur | 01-01-2019 |
Eerdere bekende functies van Pernilla Abrahamsson
| Bedrijven | Functie | Einde |
|---|---|---|
| SENZIME AB | Corporate Officer/Principal | 01-04-2019 |
MD Biomedical AB
 MD Biomedical AB Medical/Nursing ServicesHealth Services Part of Senzime AB, MD Biomedical AB provides micro dialysis products and services. The company is based in Umeå, Sweden. The Swedish company was founded in 2011 by Pernilla Abrahamsson. MD Biomedical was acquired by Senzime AB on April 21, 2015 for $0.24 million. | Oprichter | - |
Opleiding van Pernilla Abrahamsson
| Umea Universitet | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 2 |
|---|---|
| SENZIME AB | Health Technology |
| LIPUM AB | Health Technology |
| Bedrijven in privébezit | 1 |
|---|---|
MD Biomedical AB
MD Biomedical AB Medical/Nursing ServicesHealth Services Part of Senzime AB, MD Biomedical AB provides micro dialysis products and services. The company is based in Umeå, Sweden. The Swedish company was founded in 2011 by Pernilla Abrahamsson. MD Biomedical was acquired by Senzime AB on April 21, 2015 for $0.24 million. | Health Services |
